Expanded access programs expanding.

  • Published 1997 in Project Inform perspective
Abacavir (GW1592), adefovir (Preveon), and efavirenz (Sustiva) are currently available in expanded access programs. The old expanded access program protocols that supplied only one drug have been scrubbed for new multi-drug dosing regimens. The protocols using CD4+ cell and viral load limits as entry criteria have also been eliminated. The new recommended… CONTINUE READING